Antoine V.
- Country
- France
- Department
- Nuclear medicine
Research Overview
- Evaluation of diagnostic performances of 18F-FDOPA PET KInetics as biomarkers for the improvement of care of MRI Non-contrast enhanced Gliomas : a phase IIIb exploratory trial
- Phase IIb Trial of Everolimus and Lutetium (177Lu) Oxodotreotide in Refractory Grade 2 and 3 Meningioma
- Phase II Randomized Study of [177Lu]Lu-DOTATATE in Recurrent Meningioma Lacking Surgical or Radiotherapeutic Options
Data & Insights
Has run more than one trial at 12 of 53 partner sites.
Specializations
Neuro-Oncology Focus
This investigator specializes in the treatment and research of primary brain tumors, with particular emphasis on low-grade gliomas and meningiomas.
- Advanced Glioma Diagnostics
- Meningioma Treatment Innovation
- Brain Tumor Management
The research focus includes grade 2 and 3 meningiomas and assessment of glioma characteristics.
Nuclear Medicine Applications
Expertise in utilizing advanced nuclear medicine techniques for brain tumor diagnosis and treatment, including PET imaging and radionuclide therapy.
- PET Imaging Biomarkers
- Radiopharmaceutical Treatment
- Molecular Imaging
Specialization in 18F-FDOPA PET kinetics and Lu-DOTATATE applications in neurological conditions.
Therapeutic Innovation
Development of novel therapeutic approaches for challenging brain tumors, focusing on combination therapies and targeted treatments.
- Refractory Tumor Treatment
- Combined Therapy Strategies
- Treatment Response Assessment
Investigation of innovative treatment combinations for brain tumors resistant to conventional therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.